These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3491878)

  • 41. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
    Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
    Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds.
    Demushkin VP; Fomenko AM; Plyashkevich YG; Shchurin MR; Brusov OS
    Eur J Pharmacol; 1987 Aug; 140(2):171-8. PubMed ID: 2822438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imipramine binding sites in brain and platelets: role in affective disorders.
    Hrdina PD
    Int J Clin Pharmacol Res; 1989; 9(2):119-22. PubMed ID: 2541089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier.
    Phillips OM; Wood KM; Williams DC
    Eur J Pharmacol; 1988 Feb; 146(2-3):299-306. PubMed ID: 3371401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants.
    Plenge P; Mellerup ET; Honoré T; Honoré PL
    J Pharm Pharmacol; 1987 Nov; 39(11):877-82. PubMed ID: 2892909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.
    Raisman R; Briley MS; Bouchami F; Sechter D; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1982; 77(4):332-5. PubMed ID: 6813892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.
    Malmgren R
    Psychopharmacology (Berl); 1986; 90(3):384-9. PubMed ID: 3097728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uptake of 5-hydroxytryptamine in blood platelets and its inhibition by drugs: role of plasma membrane and granular storage.
    Laubscher A; Pletscher A
    J Pharm Pharmacol; 1979 May; 31(5):284-9. PubMed ID: 37296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 5-Hydroxytryptamine uptake and imipramine binding sites in neurotumor NCB-20 cells.
    Nakaki T; Roth BL; Chuang DM; Costa E
    J Neurochem; 1985 Sep; 45(3):920-5. PubMed ID: 3875688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet serotonin transporter in coeliac disease.
    Chiaravalloti G; Marazziti D; Batistini A; Favilli T; Ughi C; Ceccarelli M; Cassano GB
    Acta Paediatr; 1997 Jul; 86(7):696-9. PubMed ID: 9240875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus.
    Hensler JG; Ferry RC; Labow DM; Kovachich GB; Frazer A
    Synapse; 1994 May; 17(1):1-15. PubMed ID: 8042142
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective effects of thiol reagents on the binding sites for imipramine and neurotransmitter amines in the rat brain.
    Biassoni R; Vaccari A
    Br J Pharmacol; 1985 Jun; 85(2):447-56. PubMed ID: 2992663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High affinity [3H]paroxetine binding to serotonin uptake sites in human brain tissue.
    Bäckström I; Bergström M; Marcusson J
    Brain Res; 1989 May; 486(2):261-8. PubMed ID: 2525060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chlorimipramine--but not imipramine--rapidly reduces [3H]imipramine binding in human platelet membranes.
    Mellerup ET; Plenge P
    Eur J Pharmacol; 1986 Jul; 126(1-2):155-8. PubMed ID: 3758160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased platelet 3H-imipramine binding sites in classical migraine.
    Geaney DP; Rutterford MG; Elliott JM; Schächter M; Peet KM; Grahame-Smith DG
    J Neurol Neurosurg Psychiatry; 1984 Jul; 47(7):720-3. PubMed ID: 6086845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [3H]-5-methoxytryptoline is not actively accumulated by rabbit platelets.
    Segonzac A; Schoemaker H; Lee CR; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):1-4. PubMed ID: 3627287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kinetic effects of desmethylimipramine treatment on platelet serotonin uptake in depressed patients: a comparison with imipramine.
    Rausch JL; Moeller FG
    Psychiatry Res; 1991 Mar; 36(3):299-305. PubMed ID: 2062971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Function of the serotoninergic system of blood platelets in patients with hypertension].
    Krivonkin KIu; Belousov IuB; Brusov OS; Katasonov AB; Zlobina GP; Faktor MI
    Kardiologiia; 1992; 32(11-12):10-2. PubMed ID: 1297866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of sodium-dependent [3H]imipramine binding in rat brain by serotonin and serotonin uptake inhibitors.
    Hrdina PD
    Eur J Pharmacol; 1988 Mar; 148(2):279-82. PubMed ID: 3259932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.